by European Public Health Alliance | Dec 13, 2018 | #EU4Health, Universal Access and Affordable Medicines | Latest Developments
Civil society reaction to the European Parliament’s position on Horizon Europe 12 DEC. The European Commission’s original proposal for Horizon Europe failed to include concrete measures that would help to maximise public return on investments for publicly funded...
by European Public Health Alliance | Dec 12, 2018 | Roma Health and ECD | Analysis and Opinion | Roma Fellows
By Marcela Adamová, EPHA Roma Health Fellow NCDs cost us a fortune Non-communicable diseases (NCDs) are the world’s leading avoidable killers, but the society we live in is not doing enough to prevent and control their occurrence. NCDs cause most of the early deaths...
by European Public Health Alliance | Dec 11, 2018 | Antimicrobial Resistance | Latest Developments
By Vladimir Kolev, Policy Assistant, EPHA Undoubtedly, vaccination is one of the biggest achievements in modern medicine, protecting us against infectious diseases, saving many lives and reducing illness. At the same time, it is a way to fight one of the biggest...
by European Public Health Alliance | Dec 11, 2018 | Antimicrobial Resistance | Analysis & Opinion
Ber Oomen, Executive Director, ESNO, European Specialist Nurses Organisation Despite the many meetings at European level, and funding for research and data collection Antimicrobial Resistance (AMR) continues to concern many health stakeholders. The initiatives at EU...
by European Public Health Alliance | Dec 11, 2018 | Antimicrobial Resistance | Analysis & Opinion
Stephanie Kohl Policy & Advocacy Officer, European Association of Hospital Pharmacists Antimicrobial Resistance threatens to endanger many patients’ lives. The loss of effective antimicrobials is pushing modern medicine back into the pre-antibiotic area....
